Beogene

Guangzhou Beogene Biotech Co., Ltd. was established in 2011. With the mission of "providing high-quality medical device services," the company is committed to becoming a platform for clinical demand solutions and a platform for the transformation of biomedical materials and health technologies. The company is a Guangzhou science and technology innovation "Little Giant" enterprise, a high-tech enterprise, the Guangdong Provincial Drug Carrier Development Engineering Technology Research Center (relying unit), and a Guangdong Postdoctoral Innovation Practice Base. It has also built a Guangzhou Enterprise Research and Development Institution and was approved in 2019 to establish an Academician Expert Workstation (one of the first 19 units in Guangzhou). The company has a comprehensive R&D and production platform with equipment valued at over ten million yuan, meeting scientific research and production requirements. The company has been focusing on the R&D and industrialization of biomaterials for medical use. It has passed the Medical Device Quality Management System (ISO13485:2016) and Occupational Health and Safety Management System (ISO45001:2018) certifications. The company adheres to market demand orientation, organizes industry-academia-research-medical collaboration based on its independent R&D and innovation capabilities, and establishes efficient resource integration and cooperation mechanisms. It continuously improves R&D technology, strengthens brand promotion, expands sales scale to increase market share, and is committed to maximizing R&D value, ultimately enabling cutting-edge medical and health technologies to better and more quickly serve the public.